A team of Rambam cardiologists were the first in Israel to use a new, Israeli-developed technology to repair mitral valve regurgitation, as part of a multi-national clinical trial. The implantable device, recently acquired by a US leader in cardiology solutions from an Israeli start-up, is minimally invasive, and saves patients the need to undergo protracted and complex open-heart surgery.
